Harm Reduction International developed tools for assessing national harm reduction investment and spending on drug law enforcement. This report presents the research findings generated by these tools in seven Asian countries. It provides insights on the state of harm reduction financing, informed by donor and government stakeholders, civil society and community representatives. It outlines evidence that can be used to inform advocacy for increased domestic and donor support for harm reduction, covering factors that underpin sustainability and those that pose challenges. It also explores spending on drug law enforcement in two countries, which can be used to inform advocacy for rebalancing drug policy investments towards health and harm reduction.
- FAST-TRACK or OFF TRACK? How insufficient funding for key populations jeopardises ending AIDS by 2030
- Women and barriers to harm reduction services: A literature review and initial findings from a qualitative study in Barcelona, Spain
- Clean Start: Creating second chances for women and girls in Kenya
- Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply
- How diverse is Canada’s legal cannabis industry? Examining race and gender of its executives and directors
- Coca and Its medical applications: Prospects, obstacles and lessons learned
- Funding what is possible. Robert Carr fund annual report 2019.
- The impact of arrest and seizure on drug crime and harms: A systematic review
- Addressing stigma and discrimination in the COVID-19 response